MSH RELEASE INHIBITING FACTOR

\ˌɛmˌɛsˈe͡ɪt͡ʃ ɹɪlˈiːs ɪnhˈɪbɪtɪŋ fˈaktə], \ˌɛmˌɛsˈe‍ɪt‍ʃ ɹɪlˈiːs ɪnhˈɪbɪtɪŋ fˈaktə], \ˌɛ_m_ˌɛ_s_ˈeɪ_tʃ ɹ_ɪ_l_ˈiː_s ɪ_n_h_ˈɪ_b_ɪ_t_ɪ_ŋ f_ˈa_k_t_ə]\

Definitions of MSH RELEASE INHIBITING FACTOR

Sort: Oldest first
 
2010 - Medical Dictionary Database
By DataStellar Co., Ltd

Word of the day

Proto Oncogene Proteins c erbB 2

  • cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.
View More